HIGHLIGHTS
- who: Zhichao Tian from the United Kingdom McGill University, Canada have published the research work: PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas, in the Journal: (JOURNAL)
- future: The research strategy and future direction of PD1/L1 inhibitor plus chemotherapy in the treatment of sarcoma are discussed to provide a reference for studies on the treatment of advanced sarcomas. immune_response thereby increasing the anti-tumor effects.
SUMMARY
Larger tumor lesions can inhibit the function of the systemic immune system, and reduction in the tumor lesions caused by chemotherapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.